Price sensitiveFiled Jun 05 · 11:42
BEXIMCOBeximco LtdConglomerate
Subsidiary Beximco Pharma signs MoU with Aspen South Africa for vaccine fill-finish capacity.
Beximco Limited disclosed today that its pharmaceutical subsidiary has entered into a Memorandum of Understanding with Aspen South Africa for a vaccine fill-finish partnership. The arrangement is expected to add up to USD 14M of annualised revenue over a 24-month ramp.